nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—uterine cervix—vulva cancer	0.204	0.204	CbGeAlD
Tofisopam—PDE2A—urethra—vulva cancer	0.188	0.188	CbGeAlD
Tofisopam—PDE2A—mammalian vulva—vulva cancer	0.179	0.179	CbGeAlD
Tofisopam—PDE2A—vagina—vulva cancer	0.138	0.138	CbGeAlD
Tofisopam—PDE10A—lymph node—vulva cancer	0.0895	0.0895	CbGeAlD
Tofisopam—PDE2A—lymph node—vulva cancer	0.0895	0.0895	CbGeAlD
Tofisopam—PDE4A—lymph node—vulva cancer	0.0616	0.0616	CbGeAlD
Tofisopam—PDE3A—lymph node—vulva cancer	0.0509	0.0509	CbGeAlD
